Artículos por temáticas

Respiratory-Swallow Coordination Training and Voluntary Cough Skill Training: A Single-Subject Treatment Study in a Person With Parkinson's Disease

Curtis JA, Dakin AE, Troche MS.

J Speech Lang Hear Res. 2020 Feb 26;63(2):472-486. doi: 10.1044/2019_JSLHR-19-00207. Epub 2020 Feb 20.

Longitudinal change in autonomic symptoms predicts activities of daily living and depression in Parkinson's disease

Sklerov M, Shih CH, Browner N, Palma JA, Styner M, Dayan E.

Clin Auton Res. 2020 Jun;30(3):223-230. doi: 10.1007/s10286-020-00672-7. Epub 2020 Feb 20.

Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson's disease

Lewis FW, Fairooz S, Elson JL, Hubscher-Bruder V, Brandel J, Soundararajan M, Smith D, Dexter DT, Tétard D, Pienaar IS.

Arch Toxicol. 2020 Mar;94(3):813-831. doi: 10.1007/s00204-020-02672-y. Epub 2020 Feb 20.

MicroRNA-150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease

Li H, Yu L, Li M, Chen X, Tian Q, Jiang Y, Li N.

Mol Genet Genomic Med. 2020 Apr;8(4):e1189. doi: 10.1002/mgg3.1189. Epub 2020 Feb 20.

Strategies for the Treatment of Parkinson's Disease: Beyond Dopamine

Iarkov A, Barreto GE, Grizzell JA, Echeverria V.

Front Aging Neurosci. 2020 Jan 31;12:4. doi: 10.3389/fnagi.2020.00004. eCollection 2020.

Corticomuscular control of walking in older people and people with Parkinson's disease

Roeder L, Boonstra TW, Kerr GK.

Sci Rep. 2020 Feb 19;10(1):2980. doi: 10.1038/s41598-020-59810-w.

Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease

Liu R, Umbach DM, Tröster AI, Huang X, Chen H.

Parkinsonism Relat Disord. 2020 Mar;72:23-30. doi: 10.1016/j.parkreldis.2020.02.001. Epub 2020 Feb 11.

Attenuated baroreflex in a Parkinson's disease animal model coincides with impaired activation of non-C1 neurons

Cabral LM, Moreira TS, Takakura AC, Falquetto B.

Auton Neurosci. 2020 Feb 15;225:102655. doi: 10.1016/j.autneu.2020.102655. Online ahead of print.

Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease

de Oliveira Junior ER, Truzzi E, Ferraro L, Fogagnolo M, Pavan B, Beggiato S, Rustichelli C, Maretti E, Lima EM, Leo E, Dalpiaz A.

J Control Release. 2020 May 10;321:540-552. doi: 10.1016/j.jconrel.2020.02.033. Epub 2020 Feb 21.

Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease

Amara AW, Wood KH, Joop A, Memon RA, Pilkington J, Tuggle SC, Reams J, Barrett MJ, Edwards DA, Weltman AL, Hurt CP, Cutter G, Bamman MM.

Mov Disord. 2020 Jun;35(6):947-958. doi: 10.1002/mds.28009. Epub 2020 Feb 24.

Implications of the Gut Microbiome in Parkinson's Disease

Elfil M, Kamel S, Kandil M, Koo BB, Schaefer SM.

Mov Disord. 2020 Jun;35(6):921-933. doi: 10.1002/mds.28004. Epub 2020 Feb 24.

Response to: Residence near power lines and risk of Alzheimer's dementia and Parkinson's disease

Gervasi F, Murtas R, Decarli A, Russo AG.

Int J Epidemiol. 2020 Apr 1;49(2):701-702. doi: 10.1093/ije/dyaa024.

Residence near power lines and risk of Alzheimer's dementia and Parkinson's disease

Su L, Zhu L, Chen G.

Int J Epidemiol. 2020 Apr 1;49(2):700-701. doi: 10.1093/ije/dyaa023.

Cognitive anosognosia is associated with frontal dysfunction and lower depression in Parkinson's disease

Yoo HS, Chung SJ, Lee YH, Ye BS, Sohn YH, Lee PH.

Eur J Neurol. 2020 Jun;27(6):951-958. doi: 10.1111/ene.14188. Epub 2020 Mar 20.

Development of a Physiologically Based Pharmacokinetic Model for Prediction of Pramipexole Pharmacokinetics in Parkinson's Disease Patients With Renal Impairment

You X, Wu W, Xu J, Jiao Z, Ke M, Huang P, Lin C.

J Clin Pharmacol. 2020 Feb 24. doi: 10.1002/jcph.1593. Online ahead of print.